About GPI-anchor transamidase
GPI-anchor transamidase (PIGK) is a protein
from Homo sapiens identified by UniProt accession
Q92643, 395 residues long.
MolForge cross-references it against 0 known binders and
41 disease associations.
Target properties
| Protein name | GPI-anchor transamidase |
| UniProt accession | Q92643 |
| Gene | PIGK |
| Organism | Homo sapiens |
| Length | 395 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (41)
Diseases linked to this target (Open Targets).
- neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures · score 0.73
- neurodegenerative disease · score 0.48
- chronotype measurement · score 0.24
- genetic disorder · score 0.19
- circadian rhythm · score 0.17
- lysosomal storage disease · score 0.17
- sleep duration · score 0.08
- excessive daytime sleepiness measurement · score 0.08
- insomnia measurement · score 0.08
- neoplasm · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q92643-F1 | alphafold | PREDICTED | 85.04 | — |
Amino-acid sequence (395 residues)
MAVTDSLSRA ATVLATVLLL SFGSVAASHI EDQAEQFFRS GHTNNWAVLV CTSRFWFNYR HVANTLSVYR SVKRLGIPDS HIVLMLADDM ACNPRNPKPA TVFSHKNMEL NVYGDDVEVD YRSYEVTVEN FLRVLTGRIP PSTPRSKRLL SDDRSNILIY MTGHGGNGFL KFQDSEEITN IELADAFEQM WQKRRYNELL FIIDTCQGAS MYERFYSPNI MALASSQVGE DSLSHQPDPA IGVHLMDRYT FYVLEFLEEI NPASQTNMND LFQVCPKSLC VSTPGHRTDL FQRDPKNVLI TDFFGSVRKV EITTETIKLQ QDSEIMESSY KEDQMDEKLM EPLKYAEQLP VAQIIHQKPK LKDWHPPGGF ILGLWALIIM VFFKTYGIKH MKFIF
Explore GPI-anchor transamidase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets